Streetbeat News

Partnerships

EDIT

Editas Medicine has entered a nonexclusive license agreement with Genevant Sciences to combine Editas' CRISPR Cas12a genome editing systems with Genevant's LNP technology. This collaboration aims to develop in vivo gene editing medicines targeting two undisclosed areas in Editas' upregulation strategy.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:33 pm

NKE

Nike has extended its partnership with the NBA, WNBA, and NBA G League through 2037 in a 12-year deal, continuing as the exclusive on-court uniform and apparel provider. The agreement emphasizes innovation and storytelling to enhance the game for future generations.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:19 pm

NKE

Nike has signed a 12-year extension with the NBA and WNBA to be the exclusive on-court uniform and apparel provider. This partnership includes outfitting, merchandising, marketing, and content for the NBA, WNBA, and NBA G League.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:17 pm

BLND

SSB

SouthState Bank has implemented Blend's Close solution, significantly reducing mortgage closing times and enhancing borrower satisfaction. This transformation has improved operational efficiency, cutting loan processing from 7 days to 48 hours.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:14 pm

HTZ

JPMorgan has downgraded Hertz Global Holdings Inc (NASDAQ:HTZ) to 'Underweight', citing challenges such as declining EBITDA, inability to generate positive free cash flow, and a $1 billion loss from its green initiative. Hertz's partnerships and potential earnings growth were overestimated, leading to a scrapped $5 price target for December 2024. The company faces a $272 million bill related to its past bankruptcy, and is not expected to return to normalized earnings until after 2026.

Portfolio Pulse from Anthony Noto

October 21, 2024 | 8:13 pm

ESEA

Euroseas has secured 3-year charter contracts for three new eco-friendly 2,800 TEU feeder containerships. The contracts are set for a minimum of 34 months and a maximum of 36 months, with a daily rate of $32,000.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 8:07 pm

NVDA

TSM

Nvidia's stock has reached an all-time high due to strong AI demand, particularly for its GPUs. The company is experiencing high demand for its next-gen Blackwell GPU platform. Nvidia's upcoming earnings report and partnerships, like the one with Aidoc, are key focus areas. However, export restrictions pose potential challenges.

Portfolio Pulse from Vaishali Prayag

October 21, 2024 | 7:10 pm

QCOM

Qualcomm has launched the Snapdragon 8 Elite, featuring the world's fastest mobile CPU and the next-gen Qualcomm Oryon custom CPU. This new platform powers advanced on-device generative AI with enhanced privacy and multi-modal capabilities. Leading brands like Samsung, OnePlus, and Xiaomi will roll out devices using this platform in the coming weeks.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 7:02 pm

MDXXF

PharmAla Biotech Holdings Inc. will supply its LaNeo MDMA for a clinical trial at Mt. Sinai Health System, focusing on MDMA-assisted therapy. The company also terminated its agreement with CCrest Labs, opting for other distributors.

Portfolio Pulse from Juan Spínelli

October 21, 2024 | 7:00 pm

TONUSD

V3V Ventures, a $20 million VC fund, has invested $5 million in premium Telegram usernames to build crypto channels. The fund aims to leverage Telegram's growing user base and its integration with The Open Network (TON) blockchain to create effective sources of crypto news and information.

Portfolio Pulse from Justin Roberti

October 21, 2024 | 6:56 pm